Insights

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Adwords for software APIs

Adwords for software APIs

November 19, 2024

Hiring and retaining technical talent: How to build an A+ team

Hiring and retaining technical talent: How to build an A+ team

October 23, 2024

Embracing biological complexity: our investment in Passkey Therapeutics

Embracing biological complexity: our investment in Passkey Therapeutics

October 22, 2024

From blueprints to bots: AI and agentic systems for architecture, engineering and construction (AEC)

From blueprints to bots: AI and agentic systems for architecture, engineering and construction (AEC)

October 21, 2024

All applications are becoming distributed systems

All applications are becoming distributed systems

October 9, 2024

Building Skylo: Parth Trivedi’s lessons in scaling a global network

Building Skylo: Parth Trivedi’s lessons in scaling a global network

October 2, 2024

Using AI to bring clarity and precision to private market investing: Our investment in Tetrix

Using AI to bring clarity and precision to private market investing: Our investment in Tetrix

September 26, 2024

From Series A to Salesforce: Celebrating Own

From Series A to Salesforce: Celebrating Own

September 6, 2024

The enterprise decision-making engine

The enterprise decision-making engine

August 20, 2024

Breakthrough advancements in understanding climate risk: our investment in First Street

Breakthrough advancements in understanding climate risk: our investment in First Street

July 25, 2024

Celebrating a decade of curiosity

Celebrating a decade of curiosity

July 16, 2024

Non-destructive editing in design tools

Non-destructive editing in design tools

July 12, 2024

Team growth and promotions

Innovation Endeavors growth and team promotions

July 9, 2024

Rich Stern on embracing failure: Lessons from the CEO of TuneIn

Rich Stern on embracing failure: Lessons from the CEO of TuneIn

June 27, 2024

A leap in genomic medicine: why we invested in Exsilio Therapeutics

A leap in genomic medicine: why we invested in Exsilio Therapeutics

June 25, 2024